Stock comparison
Camurus AB (publ)
CAMX.ST$36.93BHealthcare Market cap, Sector
Veracyte
VCYT$4.75BHealthcare Market cap, Sector
Overall winner
Camurus AB (publ)
CAMX.ST 61 VCYT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CAMX.ST6wins
1winsVCYT
78B
D46
91A
D57
94A
C61
65C
C68
63C
D46
77B
D47
77B
D52
Side-by-side metrics
| Metric | CAMX.ST | VCYT |
|---|---|---|
| Market cap | Winner: $36.93B | $4.75B |
| P/E (TTM) | 42.6x | 34.8x Winner |
| EV/EBIT | Winner: 29.5x | 38.4x |
| ROIC (TTM) | Winner: 17.17% | 4.73% |
| Gross margin | Winner: 93.11% | 71.31% |
| Net margin | Winner: 32.47% | 16.25% |
| Revenue CAGR 5y | Winner: 33.3% | 23.89% |
| EPS CAGR 5y | 132.79% | - |
| Debt / Equity | Winner: 0.0x | 0.0x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CAMX.ST leads on
- Market cap$36.93Bvs $4.75B+87%
- ROIC (TTM)17.17%vs 4.73%+72%
- Net margin32.47%vs 16.25%+50%
- Revenue CAGR 5y33.3%vs 23.89%+28%
VCYT leads on
- P/E (TTM)34.8xvs 42.6x+18%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.